Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -15.64 | N/A |
PEG Ratio (TTM) | -0.41 | N/A |
P/S Ratio (TTM) | 0.88 | N/A |
P/B Ratio (TTM) | 1.16 | N/A |
P/FCF Ratio (TTM) | 43.41 | N/A |
Price to 5YR AVG Earnings Ratio | -4.84 | N/A |
Price to 5YR AVG FCF Ratio | -540.48 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.07% | N/A |
ROE (TTM) | -7.46% | N/A |
Net Profit Margin (TTM) | -5.35% | N/A |
ROIC 5YR AVG | -13.81% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -46.69% | 47.04% | 38.77% |
Revenue | 3.77% | 130.74% | 89.58% |
Net Income | -0.42% | 13.53% | 16.82% |
Cash Flow | 331.94% | 2,321.88% | 2,394.46% |
Health (30%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.11 | N/A |
Quick Ratio (TTM) | 1.11 | N/A |
D/E Ratio (TTM) | 0.09 | N/A |
Interest Coverage (TTM) | -1.12 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 1.47 | N/A |
LTL to 5YR AVG FCF | -15.00 | N/A |
Shares Outstanding Growth 5YR AVG | 65.30% | N/A |